Literature DB >> 9846489

Critical role of the TIE2 endothelial cell receptor in the development of definitive hematopoiesis.

N Takakura1, X L Huang, T Naruse, I Hamaguchi, D J Dumont, G D Yancopoulos, T Suda.   

Abstract

We have investigated the function of TIE2/TEK receptor tyrosine kinase in the development of definitive hematopoiesis. In the vitelline artery at 9.5 days postcoitum (d.p.c.), TIE2+ hematopoietic cells aggregated and adhered to TIE2+ endothelial cells. Soluble TIE2-Fc chimeric protein inhibited the development of hematopoiesis and angiogenesis in the para-aortic splanchnopleural mesoderm (P-Sp) explant culture, and TIE2-deficient mice showed severely impaired definitive hematopoiesis. An in vitro study revealed that Angiopoietin-1 but not Angiopoietin-2 promoted the adhesion to fibronectin (FN) through integrins in TIE2-transfected cells and primary TIE2+ cells sorted from 9.5 d.p.c. P-Sp. Adhesion of TIE2+ cells induced by Angiopoietin-1 enhanced the proliferation of hematopoietic progenitor cells.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9846489     DOI: 10.1016/s1074-7613(00)80665-2

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  84 in total

1.  Definitive hematopoietic stem cells first develop within the major arterial regions of the mouse embryo.

Authors:  M F de Bruijn; N A Speck; M C Peeters; E Dzierzak
Journal:  EMBO J       Date:  2000-06-01       Impact factor: 11.598

Review 2.  Role of hematopoietic stem cells in angiogenesis.

Authors:  T Suda; N Takakura
Journal:  Int J Hematol       Date:  2001-10       Impact factor: 2.490

3.  Rap1 promotes VEGFR2 activation and angiogenesis by a mechanism involving integrin αvβ₃.

Authors:  Sribalaji Lakshmikanthan; Magdalena Sobczak; Changzoon Chun; Angela Henschel; Jillian Dargatz; Ramani Ramchandran; Magdalena Chrzanowska-Wodnicka
Journal:  Blood       Date:  2011-06-02       Impact factor: 22.113

4.  Recombinant angiopoietin-1 restores higher-order architecture of growing blood vessels in mice in the absence of mural cells.

Authors:  Akiyoshi Uemura; Minetaro Ogawa; Masanori Hirashima; Takashi Fujiwara; Shinji Koyama; Hitoshi Takagi; Yoshihito Honda; Stanley J Wiegand; George D Yancopoulos; Shin-Ichi Nishikawa
Journal:  J Clin Invest       Date:  2002-12       Impact factor: 14.808

5.  Identification and characterization of a resident vascular stem/progenitor cell population in preexisting blood vessels.

Authors:  Hisamichi Naito; Hiroyasu Kidoya; Susumu Sakimoto; Taku Wakabayashi; Nobuyuki Takakura
Journal:  EMBO J       Date:  2011-12-16       Impact factor: 11.598

6.  The contribution of the Tie2+ lineage to primitive and definitive hematopoietic cells.

Authors:  Yuefeng Tang; Anne Harrington; Xuehui Yang; Robert E Friesel; Lucy Liaw
Journal:  Genesis       Date:  2010-09       Impact factor: 2.487

7.  Notch1 regulates progenitor cell proliferation and differentiation during mouse yolk sac hematopoiesis.

Authors:  I Cortegano; P Melgar-Rojas; L Luna-Zurita; M Siguero-Álvarez; M A R Marcos; M L Gaspar; J L de la Pompa
Journal:  Cell Death Differ       Date:  2014-02-28       Impact factor: 15.828

Review 8.  Control of vascular morphogenesis and homeostasis through the angiopoietin-Tie system.

Authors:  Hellmut G Augustin; Gou Young Koh; Gavin Thurston; Kari Alitalo
Journal:  Nat Rev Mol Cell Biol       Date:  2009-03       Impact factor: 94.444

9.  A cyclosporine-sensitive psoriasis-like disease produced in Tie2 transgenic mice.

Authors:  Daniel Voskas; Nina Jones; Paul Van Slyke; Celina Sturk; Wing Chang; Alex Haninec; Yael Olya Babichev; Jennifer Tran; Zubin Master; Stephen Chen; Nicole Ward; Maribelle Cruz; Jamie Jones; Robert S Kerbel; Serge Jothy; Lina Dagnino; Jack Arbiser; Giannoula Klement; Daniel J Dumont
Journal:  Am J Pathol       Date:  2005-03       Impact factor: 4.307

10.  Tunica interna endothelial cell kinase expression and hematopoietic and angiogenic potentials in cord blood CD34+ cells.

Authors:  Mika Wada; Yasuhiro Ebihara; Feng Ma; Hiroshi Yagasaki; Mamoru Ito; Tsuneo Takahashi; Hideo Mugishima; Shigeru Takahashi; Kohichiro Tsuji
Journal:  Int J Hematol       Date:  2003-04       Impact factor: 2.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.